Factors associated with medication adherence in patients with type 2 diabetes mellitus
Keywords:
diabetes mellitus, knowledge, treatment adherenceAbstract
Introduction: Metabolic diseases are becoming increasingly relevant to public health, which is reflected in the increase in chronic degenerative diseases such as diabetes mellitus.
Objective: To determine the factors associated with adherence to pharmacological treatment in patients with type 2 diabetes mellitus.
Methods: A cross-sectional study was conducted with 228 diabetic patients. The variables studied were: level of knowledge about diabetes mellitus, level of treatment adherence, age, sex, educational level, disease duration, and route of drug administration. Descriptive statistics were used to calculate frequencies and percentages, and bivariate analysis was performed using the chi-square test, considering significance when p < 0.05. A Poisson regression model with robust variance was applied for multivariate analysis, reporting crude and adjusted prevalence ratios (PR) with 95% confidence intervals.
Results: A significant association was found between an inadequate level of knowledge and low adherence to treatment (PRa: 1.27; 95% CI [1.080–1.501]). Protective factors for treatment adherence included educational level (PRa: 0.77; 95% CI [0.657–0.904]), the route of administration (PRa: 0.77; 95% CI [0.660–0.909]), the duration of illness (PRa: 0.84; 95% CI [0.730–0.966]).
Conclusions: The level of knowledge about type 2 diabetes mellitus is related to adherence to pharmacological treatment, making it a modifiable factor for improving disease control. Furthermore, the route of medication administration and the duration of the disease are also related to therapeutic adherence.
Downloads
References
1. Huang X, Wu Y, Ni Y, Xu H, He Y. Global, regional and national burden of type 2 diabetes mellitus caused by high BMI from 1990 to 2021, and forecasts to 2045: analysis from the Global Burden of Disease Study 2021 [Internet]. Front Public Health. 2025; 13:1515797. DOI: 10.3389/fpubh.2025.1515797
2. Zamora-Niño CF, Guibert-Patiño AL, De La Cruz-Saldaña T, Ticse-Aguirre R, Málaga G. Evaluación de conocimientos sobre su enfermedad en pacientes con diabetes tipo 2 de un hospital de Lima, Perú y su asociación con la adherencia al tratamiento [Internet]. Acta Méd Peru. 2019; 36(2):96–103. DOI: 10.35663/amp.2019.362.809
3. Ruiz Burneo L, Merino Rivera JA, Bernabé Ortiz A. Diabetes mellitus tipo 2 y características del sueño: Un estudio poblacional en Tumbes, Perú [Internet]. Rev Peru Med Exp Salud Publica. 2022; 39(1):55-64. DOI: 10.17843/rpmesp.2022.391.10755
4. International Diabetes Federation. IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes – 2025 [Internet]. Belgica; 2025. [acceso: 18/11/2025]. Disponible en: https://idf.org/media/uploads/2025/04/IDF_Rec_2025.pdf
5. Calderón-Rivera AJ. Nivel de conocimientos y aptitudes sobre complicaciones crónicas de la diabetes mellitus 2 en el Hospital Nacional PNP. Luis N. Saenz 2016 [Internet]. [Tesis de Médico Cirujano]. Lima, Perú: Universidad Ricardo Palma; 2017. [acceso: 22/11/2023]. Disponible en: https://hdl.handle.net/20.500.14138/5169
6. Masruroh NL, Pangastuti AF, Melizza N, Kurnia AD. Level of Knowledge and Family Support toward Medication Adherence among Patient with Diabetes Mellitus in Malang, Indonesia [Internet]. Indian J Forensic Med Toxicol. 2021; 15(1):1406–13. DOI: 10.37506/ijfmt.v15i1.13610
7. Díaz-García KP, Nieves-Vázquez L, de la Rosa-Hernández R. Evaluación de la adherencia terapéutica en pacientes con hipertensión arterial: un estudio transversal en una institución pública de Michoacán, México [Internet]. Rev Mex Med Fam. 2024; 11(4):99-106. DOI: 10.24875/RMF.24000082
8. Garcia AA, Villagomez ET, Brown SA, Kouzekanani K, Hanis CL. The Starr County Diabetes Education Study: Development of the Spanish-language diabetes knowledge questionnaire [Internet]. Diabetes Care. 2001; 24(1):16-21. DOI: 10.2337/diacare.24.1.16
9. Instituto Nacional de Estadística e Informática. El 39,9% de peruanos de 15 y más años de edad tiene al menos una comorbilidad. Lima: INEI; 2020. [acceso: 22/11/2023]. Disponible en: https://m.inei.gob.pe/prensa/noticias/el-399-de-peruanos-de-15-y-mas-anos-de-edad-tiene-al-menos-una-comorbilidad-12903/
10. AlShayban DM, Naqvi AA, Alhumaid O, AlQahtani AS, Islam MdA, Ghori SA, et al. Association of Disease Knowledge and Medication Adherence Among Out-Patients With Type 2 Diabetes Mellitus in Khobar, Saudi Arabia [Internet]. Front Pharmacol. 2020; 11:60. DOI: 10.3389/fphar.2020.00060
11. Alsaidan AA, Alotaibi SF, Thirunavukkarasu A, ALruwaili BF, Alharbi RH, Arnous MM, et al. Medication adherence and its associated factors among patients with type 2 diabetes mellitus attending primary health centres of Eastern Province, Saudi Arabia [Internet]. Medicina. 2023; 59(5):989. DOI: 10.3390/medicina59050989
12. Galeas Calleja NI, Raudales Moncada JC, Carías Díaz JP. Level of knowledge about type 2 diabetes and treatment adherence in Honduran population [Internet]. Población y Salud en Mesoamérica. 2024; 22(1):57421. DOI: 10.15517/psm.v22i1.57421
13. Farías-Vílchez BA, Ruíz DB. Conocimientos sobre diabetes mellitus tipo 2 y adherencia al tratamiento en pacientes del hospital Reátegui de Piura, Perú [Internet]. Acta Med Peru. 2021; 38(1):34–41. DOI: 10.35663/amp.2021.381.1119
14. Reymundez Argumedo JB. Conocimiento y adherencia al tratamiento de la diabetes mellitus tipo 2 en pacientes del Centro de Salud San Juan Bautista 2022 [Internet]. [Tesis de Médico Cirujano]. Ayacucho, Perú: Universidad Nacional de San Cristóbal de Huamanga; 2023. [acceso: 18/11/2025]. Disponible en: https://repositorio.unsch.edu.pe/items/e98336cb-1db4-4e6b-b1ef-04413c472303
15. Abebaw M, Messele A, Hailu M, Zewdu F. Adherence and associated factors towards antidiabetic medication among type II diabetic patients on follow-up at University of Gondar Hospital, Northwest Ethiopia [Internet]. Adv Nurs. 2016; 2016:1–7. DOI: 10.1155/2016/8579157
16. Briones A, Wong LI, Flores DM, Guzmán M, Castellanos M, Albavera C. Falta de adherencia al tratamiento farmacológico y factores asociados en pacientes mexicanos con diabetes mellitus tipo 2 [Internet]. Rev Méd Chile. 2022; 150(8):985-93. DOI: 10.4067/S0034-98872022000800985
17. Feleke MG, Ayalew TL, Ashager K, Ataro BA, Beyene HA. Insulin therapy adherence and associated factors among diabetes mellitus patients in Southern Ethiopia [Internet]. Diabetes Epidemiol Manage. 2025;19-20:100284. DOI: 10.1016/j.deman.2025.100284
18. Doya IF, Yahaya JJ, Ngaiza AI, Bintabara D. Low medication adherence and its associated factors among patients with type 2 diabetes mellitus attending Amana Hospital in Dar es Salaam, Tanzania: a cross-sectional study [Internet]. International Health. 2024; 16:200-207. DOI: 10.1093/inthealth/ihad042
19. Franchi C, Ardoino I, Ludergnani M, Cukay G, Merlino L, Nobili A. Medication Adherence in Community-Dwelling Older People Exposed to Chronic Polypharmacy [Internet]. J Epidemiol Community Health. 2021; 75(9):854–9. DOI: 10.1136/jech-2020-214238
20. Rahayu FP, Haryani H, Wicaksana AL. Medication, illness duration, and medication adherence among peer support groups of diabetic patients [Internet]. Int J Pharm Res. 2021; 13(1):5831–8. DOI: 10.31838/ijpr/2021.13.01.760
21. Sharma D, Goel NK, Cheema Y, Garg K. Medication adherence and its predictors among type 2 diabetes mellitus patients: a cross-sectional study [Internet]. Indian J Community Med. 2023; 48(5):781-5. DOI: 10.4103/ijcm.ijcm_744_22
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Angello Jose Muguruza Tamara, Paloma Krystel Mateus Farías
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
